TABLE OF CONTENT

Introduction to Protein Folding

Definition of Protein Folding
Importance of Proper Protein Folding

Protein Structure and Folding Process

Primary, Secondary, Tertiary, and Quaternary Structures
Chaperone Proteins and their Role

Protein Folding Diseases: Overview

Causes of Protein Misfolding
Genetic and Environmental Factors

Common Protein Folding Diseases

Alzheimer's Disease
Parkinson's Disease
Huntington's Disease
Cystic Fibrosis
Other protein folding diseases

Techniques for Studying Protein Folding Diseases

Structural Biology Methods
X-ray Crystallography
Nuclear Magnetic Resonance (NMR)
Computational Approaches
Molecular Dynamics Simulations
Bio informatics Tools

Prevention and Future Perspectives

Lifestyle and Environmental Factors

Conclusion
INTRODUCTION
Proteins are the molecular machines that control our most vital cellular functions. To
fulfill its role, a protein must first fold into its correct three-dimensional structure,
assuming complicated tertiary and sometimes quaternary conformations. Although
many aspects of folding are intrinsic to the biophysical properties of the protein itself,
the process is quite complex and susceptible to errors (Dill and MacCallum, 2012).
Proteins consist of an elaborate arrangement of interior folds that collapse into a final
thermodynamically stable structure and, for many proteins, only a modest free-energy
gain (generally only −3 to −7 kcal/mol) (Lindquist and Kelly, 2011) is associated with
correct folding of a protein compared with its innumerable potential misfolded
states.When proteins misfold or fail to attain their correct structures, it can lead to a
myriad of health issues. Diseases associated with protein misfolding are diverse and
can affect different tissues and organs throughout the body. The consequences of
these misfolding events range from neurodegenerative disorders to genetic conditions
impacting multiple system. This introduction aims to provide an overview of protein
folding diseases, shedding light on the underlying causes, implications for human
health, and the challenges posed in developing effective treatments. By delving into
the molecular intricacies of protein misfolding, we can gain insights into conditions
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and cystic
fibrosis, among others.
DEFINITION OF PROTEIN FOLDING

Protein folding is the physical process by which a linear polypeptide folds into its
characteristic and functional three-dimensional structure. Folding of a polypeptide
chain is strongly influenced by the solubility of the AA R-groups in water. Each
protein exists as an unfolded polypeptide or random coil when translated from a
sequence of mRNA to a linear chain of amino acids. This polypeptide lacks any stable
(long-lasting) three-dimensional structure (the left hand side of the neighboring
figure). Amino acids interact with each other to produce a well-defined three-
dimensional structure, the folded protein (the right hand side of the figure), known as
the native state. All the information for the native fold appears therefore to be
contained within the primary structure (Anfinsen received the Nobel Prize for this),
and proteins are self-folding (although in vivo, polypeptide folding is often assisted
additional molecules known as molecular chaperones).

Protein folding is a highly regulated and intricate phenomenon driven by various

forces, including hydrogen bonding, van der Waals interactions, hydrophobic
interactions, and electrostatic forces. The protein's journey from an unfolded or
partially folded state to its native, functional conformation involves a series of
coordinated events, often assisted by chaperone proteins and cellular machinery.
Protein folding refers to the complex and dynamic process by which a linear chain of
amino acids, synthesized during protein biosynthesis, assumes a specific three-
dimensional structure. This folded structure is crucial for the protein to perform its
biological functions effectively. Protein folding is crucial for normal physiology
including development and healthy aging, and failure of this process is related to the
pathology of diseases including neurodegeneration and cancer.

PROTEIN STRUCTURE AND FOLDING PROCESS

The primary structure of a protein is defined as the sequence of amino acids linked
together to form a polypeptide chain. Each amino acid is linked to the next amino acid
through peptide bonds created during the protein biosynthesis process. The two ends
of each polypeptide chain are known as the amino terminus (N-terminus) and the
carboxyl terminus (C-terminus). Twenty different amino acids can be used multiple
times in the same polypeptide to create a specific primary protein structure sequence.

Four stages of protein folding

The folding of a protein is a complex process, involving four stages, that gives rise to
various 3D protein structures essential for diverse functions in the human body. The
structure of a protein is hierarchically arranged, from a primary to quaternary
structure. The wide variation in amino acid sequences accounts for the different
conformations in protein structure.

Primary structure refers to the linear sequence of amino-acid residues in the

polypeptide chain.

Secondary structure is generated by formation of hydrogen bonds between atoms in

the polypeptide backbone, which folds the chains into either alpha helices or beta-
sheets.

Tertiary structure is formed by the folding of the secondary structure sheets or helices
into one another. The tertiary structure of protein is the geometric shape of the
protein. It usually has a polypeptide chain as a backbone, with one or more secondary
structures. The tertiary structure is determined by the interactions and bonding of the
amino acid side chains in the protein.

Quaternary structure results from folded amino-acid chains in tertiary structures

interacting further with each other to give rise to a functional protein such as
hemoglobin or DNA polymerase.

Factors affecting protein folding

Protein folding is a very sensitive process that is influenced by several external factors
including electric and magnetic fields, temperature, pH, chemicals, space limitation
and molecular crowding. These factors influence the ability of proteins to fold into
their correct functional forms.

Extreme temperatures affect the stability of proteins and cause them to unfold or
denature. Similarly, extreme pH, mechanical forces and chemical denaturants can
denature proteins. During denaturation, proteins lose their tertiary and secondary
structures and become a random coil. Although denaturation is not always reversible,
some proteins can re-fold under certain conditions.

Some cells contain heat shock proteins or chaperones that protect proteins in the cell
against heat denaturation. Chaperones help proteins to fold and remain folded under
extreme temperatures. They also assist misfolded proteins in unfolding and re-folding
correctly.
PROTEIN FOLDING DISEASES

Protein folding diseases also known as Protein misfolding is a flaw by which

proteins fail to reach the three-dimensional structure and thereby usually precludes
proteins from fully fielding their biological function, misfolded proteins result when a
protein follows the wrong folding pathway or energy-minimizing funnel, and
misfolding can happen spontaneously. Most of the time, only the native conformation
is produced in the cell. But as millions and millions of copies of each protein are
made during our lifetimes, sometimes a random event occurs and one of these
molecules follows the wrong path, changing into a toxic configuration. This kind of
conformational change is most likely to occur in proteins that have repetitive amino
acid motifs, such as polyglutamine; such is the case in Huntington's disease.
Misfolding is produced by an incorrect folding process that results in the
formation of a protein with a different conformation from its native fold. Protein
misfolding can occur by several reasons (i) somatic mutations in the gene sequence
leading to the production of a protein unable to adopt the native folding; (ii) errors on
the processes of transcription or translation leading to the production of modified
proteins unable to properly fold; (iii) failure of the folding and chaperone machinery;
(iv) mistakes on the post-transnational modifications or trafficking of proteins; (v)
structural modification produced by environmental changes or (vi) induction of
protein misfolding by seeding and cross-seeding mechanisms.

The most frequent destiny for misfolded proteins is self-aggregation, because the
mistaken exposure of fragments to the solvent that are normally buried inside the
protein, lead to a high degree of stickiness.

ALZHEIMER'S DISEASE

Alzheimer’s disease is the most common type of dementia.

It is a progressive disease beginning with mild memory loss and possibly leading to
loss of the ability to carry on a conversation and respond to the environment.
Alzheimer’s disease involves parts of the brain that control thought, memory, and
language.
It can seriously affect a person’s ability to carry out daily activities. Age is the best
known risk factor for Alzheimer’s disease.
Family history—researchers believe that genetics may play a role in developing
Alzheimer’s disease. However, genes do not equal destiny. A healthy lifestyle may
help reduce your risk of developing Alzheimer’s disease. Two large, long term studies
indicate that adequate physical activity, a nutritious diet, limited alcohol consumption,
and not smoking may help people.

How is Alzheimer’s disease treated?

Medical management can improve quality of life for individuals living with
Alzheimer’s disease and for their caregivers. There is currently no known cure for
Alzheimer’s disease. Treatment addresses several areas:

Helping people maintain brain health.

Managing behavioral symptoms.
Slowing or delaying symptoms of the disease.
PARKINSON DISEASE
Parkinson’s disease is a condition where a part of your brain deteriorates, causing
more severe symptoms over time. While this condition is best known for how it
affects muscle control, balance and movement, it can also cause a wide range of other
effects on your senses, thinking ability, mental health and more.

Who does it affect?

The risk of developing Parkinson’s disease naturally increases with age, and the
average age at which it starts is 60 years old. It’s slightly more common in men or
people designated male at birth (DMAB) than in women or people designated female
at birth (DFAB).

While Parkinson’s disease is usually age-related, it can happen in adults as young as

20 (though this is extremely rare, and often people have a parent, full sibling or child
with the same condition).

HUNTINGTON’S DISEASES
Huntington’s disease is an inherited condition that causes brain cells to slowly lose
function and die. It affects the cells in parts of your brain that regulate voluntary
movement and memory. Common symptoms include uncontrollable movements and
changes to your thinking, behavior and personality. These symptoms get worse over
time.
Huntington’s disease is a progressive condition. This means that your symptoms get
worse over time. Complications could include worsening symptoms, like:

Dementia (loss of brain function, memory loss, personality changes).

Physical injury from involuntary movements or falls.
Difficulty swallowing, eating or drinking (malnutrition).
Inability to walk without assistance.
Infections (pneumonia).
Children diagnosed with juvenile Huntington’s disease may experience seizures.

CYSTIC FIBRIOSIS

Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs,
digestive system and other organs in the body.
Cystic fibrosis affects the cells that produce mucus, sweat and digestive juices. These
secreted fluids are normally thin and slippery. But in people with CF, a defective gene
causes the secretions to become sticky and thick. Instead of acting as lubricants, the
secretions plug up tubes, ducts and passageways, especially in the lungs and pancreas.

Although cystic fibrosis is progressive and requires daily care, people with CF are
usually able to attend school and work. They often have a better quality of life than
people with CF had in previous decades. Improvements in screening and treatments
mean that people with CF now may live into their mid- to late 30s or 40s, and some
are living into their 50s.
Other protein folding diseases includes;

Amyotrophic lateral sclerosis

Tay sach’s disease
Marfan syndrome
Cneutzfeldt -jakob disease
Desminopathy
Transthyretin familial amyloid polyneuropathy
Sickle cell anaemia
Spinal bulbar muscular atrophy
Spinocerebellar ataxia
Multiple myeloma

CAUSES OF PROTEIN FOLDING DISEASES

Genetic Mutations:
Point Mutations: Changes in the DNA sequence can result in single amino acid
substitutions, altering the protein's folding pattern. For example, mutations in the
PRNP gene are associated with Creutzfeldt-Jakob disease.
Repeat Expansions: Expansion of repetitive DNA sequences, as seen in diseases like
Huntington's disease, can lead to abnormal protein folding.

Environmental Factors:
Temperature and pH: Changes in temperature and pH can affect protein stability and
folding. Conditions outside the optimal range may lead to misfolding.
Chemical Exposure: Exposure to certain chemicals or toxins can induce protein
misfolding. For instance, oxidative stress can contribute to the misfolding of proteins.
Protein Homeostasis (Proteostasis) Disruptions:

Chaperone Dysfunction: Molecular chaperone assist in proper protein folding. Any

disruption in chaperone function can lead to misfolding.
Proteasomal Dysfunction: The proteasome is responsible for degrading misfolded
proteins. Impaired proteasomal function can result in the accumulation of misfolded
proteins.

Aggregation-Prone Sequences: Some protein sequences are inherently prone to

misfolding and aggregation. These regions are often rich in specific amino acids, such
as glutamine or proline.
Cellular Stress:

Endoplasmic Reticulum (ER) Stress: The endoplasmic reticulum is crucial for

protein folding. Stress conditions, such as an overload of misfolded proteins, can lead
to ER stress and subsequent protein misfolding diseases.
Infectious Agents:
Prions: Misfolded proteins, known as prions, can induce the misfolding of normal
proteins. Prion diseases, like mad cow disease, are characterized by the accumulation
of abnormal prion proteins.

Age-Related Factors:

Accumulation of Damage: As cells age, there is an increased likelihood of damage to

proteins. Accumulated damage can contribute to misfolding and aggregation over
time.

Altered Post-translational Modifications;Glycosylation, Phosphorylation, etc.:

Changes in post-translational modifications can impact protein folding. For example,
abnormal glycosylation patterns have been linked to misfolding diseases.

TECHNIQUES USED FOR DETECTING PROTEIN FOLDING DISEASES

X-ray Crystallography:

Principle: X-ray crystallography is used to determine the three-dimensional structure

of proteins at atomic resolution.
Application: Provides detailed information about the folded state of proteins, helping
to understand the native conformation and potential misfolding.

Nuclear Magnetic Resonance (NMR) Spectroscopy:

Principle: NMR spectroscopy analyzes the interactions between nuclear spins in a

magnetic field, providing information about the local environment of specific atoms
in a protein.
Application: Useful for studying the dynamics of protein folding and identifying
misfolded structures.

Cryo-Electron Microscopy (Cryo-EM):

Principle: Cryo-EM uses electron microscopy to visualize protein structures at near-

atomic resolution by flash-freezing samples.
Application: Enables the study of protein aggregates, intermediates, and misfolded
conformations.

Fluorescence Spectroscopy:

Principle: Measures the fluorescence properties of proteins labeled with fluorophores,

providing information on structural changes.
Application: Useful for monitoring protein folding kinetics and detecting misfolded
conformations.
Circular Dichroism (CD) Spectroscopy:

Principle: CD spectroscopy measures the differential absorption of left- and right-

handed circularly polarized light, providing information on protein secondary
structure.
Application: Can be used to study changes in protein folding and detect alterations in
secondary structure associated with misfolding.

Mass Spectrometry:

Principle: Mass spectrometry analyzes the mass-to-charge ratio of ions, providing

information on protein structure and post-translational modifications.
Application: Useful for studying the stability and conformational changes in proteins,
including misfolded states.

Computational Modeling and Simulations:

Principle: Molecular dynamics simulations and other computational techniques model

protein folding dynamics and energetics.
Application: Helps predict protein structures, study folding pathways, and explore the
stability of misfolded conformations.

Protein Engineering:

Principle: Involves the creation of mutant proteins to study the impact of specific
amino acid changes on folding.
Application: Helps identify key residues involved in proper folding and understand
the consequences of mutations leading to misfolding.

Thermal and Chemical Denaturation:

Principle: Involves exposing proteins to elevated temperatures or chemical

denaturants to induce unfolding.
Application: Provides insights into the thermodynamics and kinetics of protein
folding, including the propensity for misfolding.

PREVENTION AND TREATMENT TECHNIQUES

Genetic Counseling:

Identify individuals with a family history of protein folding diseases and provide
genetic counseling to assess the risk and make informed reproductive decisions.
Lifestyle Modifications:

Adopt a healthy lifestyle, including a balanced diet, regular exercise, and stress
management, to potentially reduce the risk of protein misfolding and aggregation.

Environmental Factors:

Minimize exposure to environmental factors that may contribute to protein

misfolding, such as toxins and pollutants.

Antioxidant Supplementation:

Antioxidants may help reduce oxidative stress, which is implicated in some protein
folding diseases. However, the evidence is mixed, and more research is needed.

Treatment Strategies:
Pharmacological Interventions:

Chaperone Therapy: Small molecules or peptides that act as molecular chaperones to

assist in proper protein folding.
Proteostasis Regulators: Compounds that modulate the cellular machinery responsible
for protein homeostasis.

Immunotherapy:
Develop antibodies or other immune-based therapies to target and clear misfolded
protein aggregates.

Gene Therapies:
Use gene editing technologies (e.g., CRISPR-Cas9) to correct or replace mutated
genes associated with protein folding diseases.

Anti-Aggregation Agents:
Investigate compounds that can disrupt or inhibit the formation of protein aggregates.

Enhancing Protein Clearance:

Develop therapies that enhance the clearance of misfolded proteins through autophagy
or the ubiquitin-proteasome system.

Stem Cell Therapy:

Explore the potential of stem cell transplantation to replace damaged or degenerated
cells affected by protein misfolding.

Symptomatic Treatments:
Alleviate symptoms associated with protein folding diseases through medications or
therapies designed to improve cognitive function, motor skills, or other affected
functions.

Clinical Trials and Research:

Participate in or support ongoing clinical trials and research aimed at discovering
novel treatments and interventions.
CONCLUSION

A large number of neurodegenerative diseases in humans result from protein

misfolding and aggregation. Protein misfolding is believed to be the primary cause of
Alzheimer's disease, Parkinson's disease, Huntington's disease, Creutzfeldt-Jakob
disease, cystic fibrosis, Gaucher's disease and many other degenerative and
neurodegenerative disorders. Cellular molecular chaperones, which are ubiquitous,
stress-induced proteins, and newly found chemical and pharmacological chaperones
have been found to be effective in preventing misfolding of different disease-causing
proteins, essentially reducing the severity of several neurodegenerative disorders and
many other protein-misfolding diseases. In this review, we discuss the probable
mechanisms of several protein-misfolding diseases in humans, as well as therapeutic
approaches for countering them. The role of molecular, chemical and pharmacological
chaperones in suppressing the effect of protein misfolding-induced consequences in
humans is explained in detail. Functional aspects of the different types of chaperones
suggest their uses as potential therapeutic agents against different types of
degenerative diseases, including neurodegenerative disorders.
REFERENCES
Alper, T. et al. Does the agent of scrapie replicate without nucleic acid? Nature 214,
764–766 (1967)

Anfinsen, C. B. The formation and stabilization of protein structure. Biochemical

Journal 128, 737–749 (1972)

Beadle, G. W. & Tatum, E. L. Genetic control of biochemical reactions in

Neurospora. PNAS 27, 499–506 (1941)

Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease.
Annual Review of Biochemistry 75, 333–366 (2006)

Dill, K. A. & Chan, H. S. From Levinthal to pathways to funnels. Nature Structural

Biology 4, 10–19 (1997)

Dobson, C. M. Protein folding and misfolding. Nature 426, 884–890 (2003)

doi:10.1038/nature02261

Dobson, C. M. Protein misfolding diseases: Getting out of shape. Nature 418, 729–
730 (2002) doi:10.1038/418729a

Ellis, J. Proteins as molecular chaperones. Nature 328, 378–379 (1987)

doi:10.1038/328378a0

Fändrich, M. & Dobson, C. M. The behaviour of polyamino acids reveals an inverse

side chain effect in amyloid structure formation The EMBO Journal 21, 5682-5690
(2002).

Finkel, T. Radical medicine: Treating ageing to cure disease. Nature Reviews

Molecular Cell Biology 6, 971–976 (2005)

Gajdusek, D. C., Gibbs, C. J., Jr. & Alpers, M. Transmission and passage of
experimental "kuru" to chimpanzees. Science 155, 212–214 (1967)

Gamow, G. & Ycas, M. Statistical correlation of protein and ribonucleic acid

composition. PNAS 41, 1011–1019 (1955)

Griffith, J. S. Self-replication and scrapie. Nature 215, 1043–1044 (1967)

Kaufman, R. J., et al. The unfolded protein response in nutrient sensing and
differation. Nature Reviews Molecular Cell Biology 3, 411-421 (2002)

Laskey, R. A. et al. Nucleosomes are assembled by an acidic protein which binds

histones and transfers them to DNA. Nature 275, 416–420 (1978)
doi:10.1038/275416a0

Levinthal, C. Are there pathways for protein folding? Journal de Chimie Physique et
de Physico-Chimie Biologique 65, 44–45 (1968)
Lin, M. Y. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in
neurodegenerative diseases. Nature 443, 787–795 (2006)

Nirenberg, M. W. & Matthaei, H. The dependence of cell-free protein synthesis in E.

coli upon RNA prepared from ribosomes. Biochemical and Biophysical Research
Communications 4, 404–408 (1961)

Pauling, L., Corey, R. B. & Branson, H. R. The structure of proteins: Two hydrogen-
bonded helical configurations of the polypeptide chain. PNAS 37, 205–211 (1951)

Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216,

136–144 (1982)

Smith, M. A. et al. Effect of polyadenylic acid chain length on the size distribution of
lysine peptides. Acta Biochimica Polonica 13, 361–365 (1966)